Analyst Reco. MacroGenics, Inc.

Equities

MGNX

US5560991094

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
15.22 ^USD	-2.12%		+5.92%	+58.21%

26/04	B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target	MT
10/04	North American Morning Briefing : Traders Await -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target	26/04	MT
TD Cowen Upgrades MacroGenics to Buy From Hold	09/04	MT
JMP Securities Adjusts Price Target on MacroGenics to $22 From $16, Maintains Market Outperform Rating	11/03	MT
HC Wainwright Adjusts Price Target on MacroGenics to $16 From $14, Maintains Neutral Rating	11/03	MT
Stifel Adjusts Price Target on MacroGenics to $29 From $17, Keeps Buy Rating	08/03	MT
BMO Capital Adjusts Price Target on MacroGenics to $24 From $18, Maintains Outperform Rating	08/03	MT
BTIG Adjusts Price Target on MacroGenics to $24 From $12, Maintains Buy Rating	04/03	MT
Barclays Raises Price Target on MacroGenics to $23 From $12, Maintains Overweight Rating	29/02	MT
HC Wainwright Downgrades MacroGenics to Neutral From Buy, Adjusts Price Target to $14 From $12	14/02	MT
JMP Securities Adjusts MacroGenics' Price Target to $16 From $10, Maintains Market Outperform Rating	25/01	MT
Citigroup Upgrades MacroGenics to Buy From Neutral, Raises Price Target to $13 From $7	20/12	MT
HC Wainwright Cuts MacroGenics' Price Target to $12 From $14, Keeps Buy Rating	13/11	MT
Guggenheim Upgrades MacroGenics to Buy From Neutral, Price Target is $12	07/11	MT
JMP Securities Adjusts Price Target on MacroGenics to $10 From $8, Maintains Market Outperform Rating	11/23/11	MT
BTIG Adjusts Price Target on MacroGenics to $12 From $6, Maintains Buy Rating	21/23/21	MT
HC Wainwright Adjusts MacroGenics Price Target to $14 From $12, Maintains Buy Rating	20/23/20	MT
Guggenheim Downgrades MacroGenics to Neutral From Buy	17/23/17	MT
Citigroup Downgrades MacroGenics to Neutral From Buy, Adjusts Price Target to $7 From $16	23/22/23	MT
Cowen Downgrades MacroGenics to Market Perform From Outperform	22/22/22	MT
HC Wainwright Adjusts Price Target on MacroGenics to $12 From $11, Maintains Buy Rating	07/22/07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. MacroGenics, Inc.

Equities

MGNX

US5560991094

Analyst Reco.

Filters